Status:
COMPLETED
The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Exploratory Behavior
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Our objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose with and without lactisole and exendin as well as f...
Eligibility Criteria
Inclusion
- right-handed healthy males, no drugs, non-smoking
Exclusion
- drug abuse, smoker, left-handed, claustrophobia
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01918566
Start Date
March 1 2012
End Date
March 1 2013
Last Update
August 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Basel, Switzerland, CH-4031